N
Nada Jabado
H-index:107
Citation Count:4.8万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
H3K27M cooperates with ASCL1 to maintain progenitor states and drive gliomagenesis
H3K27M与ASCL1协同作用以维持祖细胞状态并驱动胶质瘤发生
Nature Communications
IF15.7
CD155 regulates tumor growth and susceptibility to T cell-mediated killing in diffuse midline glioma
CD155调控弥漫性中线胶质瘤的生长及对T细胞介导杀伤的易感性
Neuro-Oncology
IF13.4
H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs
H3K27me3扩散组织规范PRC1染色质结构以调节发育程序
Nature Genetics
IF29
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma
雄性胚胎后脑中的雄激素活性驱动致死性PFA室管膜瘤
Nature
IF48.5
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
作者更正:FGFR 突变和共突变的多样化景观表明儿童低级别胶质瘤中存在潜在的治疗策略
Nature Communications
IF15.7
AGE-APPROPRIATE MODELS OF PAEDIATRIC BRAIN TUMOURS REVEAL THE INFLUENCE OF AGE ON TUMOUR-IMMUNE INTERACTION.
年龄适宜的儿童脑肿瘤模型揭示了年龄对肿瘤-免疫相互作用的影响。
NEURO-ONCOLOGY
IF13.4
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma
MAPK激活的免疫抑制性髓系细胞群在儿童低级别胶质瘤中的空间分布图
Nature Immunology
IF27.6
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
FGFR变异和共突变多样性的景观表明儿科低级别胶质瘤存在潜在的治疗策略
Nature Communications
IF15.7
Aberrant EZHIP expression drives tumorigenesis in osteosarcoma
异常的EZHIP表达驱动骨肉瘤中的肿瘤发生
Nature Communications
IF15.7
Germline analysis of an international cohort of pediatric diffuse midline glioma patients
对国际队列儿童弥漫性中线胶质瘤患者的生殖系分析
NEURO-ONCOLOGY
IF13.4
Think zebras: challenges and opportunities for treating rare cancers
思考斑马:治疗罕见癌症的挑战与机遇
TRENDS IN CANCER
IF17.5
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial
在FIREFLY-1试验中,托瓦雷芬尼(tovorafenib)这种II型RAF抑制剂对复发性/难治性视神经通路胶质瘤患儿的放射学和视觉反应。
NEURO-ONCOLOGY
IF13.4
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study
维利帕尼,局部放疗和替莫唑胺在新诊断的高级别神经胶质瘤患者中的2期试验: 儿童肿瘤学小组研究
NEURO-ONCOLOGY
IF13.4

